Potassium chloride
- Generic Name
- Potassium chloride
- Brand Names
- Bi-peglyte, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Colyte, Dextrose and Electrolyte No. 75, Diphen, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Glycerolyte 57, Golytely, H.E.L.P.bicel, Hemosate Ultra, Ionosol-MB, Isolyte P, Isolyte S, Isolyte S pH 7.4, Isoplate, K 45, K-tab, Klor-con, Lactated Ringers, Moviprep, Naturalyte, Normosol-R, Nulytely, Nxstage Pureflow, Olimel, Peglyte, Periolimel, Phoxillum, Physiolyte, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Pokonza, Prismasol, Procalamine 3, Ringers, Selectbag One, Suflave, Tis-U-sol
- Drug Type
- Small Molecule
- Chemical Formula
- ClK
- CAS Number
- 7447-40-7
- Unique Ingredient Identifier
- 660YQ98I10
- Background
A white crystal or crystalline powder used as an electrolyte replenisher, in the treatment of hypokalemia, in buffer solutions, and in fertilizers and explosives.
The FDA withdrew its approval for the use of all solid oral dosage form drug products containing potassium chloride that supply 100 mg or more of potassium per dosage unit, except for controlled-release dosage forms and those products formulated for preparation of solution prior to ingestion.
- Indication
For use as an electrolyte replenisher and in the treatment of hypokalemia.
- Associated Conditions
- Dehydration, Dry Mouth, Hypokalemia, Hypotonic Dehydration, Hypovolaemia, Isotonic Dehydration, Markedly Reduced Food Intake, Metabolic Acidosis, Hypodermoclysis, Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis, Ocular edema
- Associated Therapies
- Acid- Base Balance, Bowel preparation therapy, Electrolyte replacement, Fluid replacement therapy, Haemofiltration, Hemodialysis Treatment, Parenteral Nutrition, Parenteral rehydration therapy, Plasma Volume Replacement, Urine alkalinization therapy, Fluid and electrolyte maintenance therapy
Effect of Preload on Bladder Retention Volume During Spinal Anesthesia
- Conditions
- DiuresisHypotensionBladder Retention Volume
- Interventions
- First Posted Date
- 2007-10-29
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Rijnstate Hospital
- Target Recruit Count
- 144
- Registration Number
- NCT00550186
- Locations
- 🇳🇱
Ziekenhuis Zevenaar, Zevenaar, Gelderland, Netherlands
Arterial Pressure Based Cardiac Output for Goal-Directed Therapy in Abdominal Surgery
- Conditions
- Major Abdominal Surgery
- Interventions
- Drug: Goal-directed hemodynamic therapyDrug: Standard of care
- First Posted Date
- 2007-10-25
- Last Posted Date
- 2009-12-23
- Lead Sponsor
- Klinikum Ludwigshafen
- Target Recruit Count
- 60
- Registration Number
- NCT00549419
- Locations
- 🇩🇪
Klinikum Ludwigshafen, Ludwigshafen, RLP, Germany
An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy
- Conditions
- Crohn's DiseaseUlcerative ColitisRectal CancerColon CancerColon PolypsRectal PolypsDiverticulitis
- First Posted Date
- 2007-05-01
- Last Posted Date
- 2009-10-21
- Lead Sponsor
- Spectrum Health Hospitals
- Target Recruit Count
- 69
- Registration Number
- NCT00467922
- Locations
- 🇺🇸
Spectrum Health, Grand Rapids, Michigan, United States
A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population
- Conditions
- Colonoscopy
- First Posted Date
- 2007-01-23
- Last Posted Date
- 2007-12-27
- Lead Sponsor
- Braintree Laboratories
- Target Recruit Count
- 150
- Registration Number
- NCT00425594
A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2006-10-18
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 12
- Registration Number
- NCT00389311
- Locations
- 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States
Safety of NGOIS Compared to BSS Plus in Pediatric Patients
- Conditions
- Cataract
- Interventions
- Drug: Next Generation Ophthalmic Irrigating Solution (NGOIS)
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2012-03-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 18
- Registration Number
- NCT00346528
- Locations
- 🇺🇸
Contact Alcon for Trial Locations, Fort Worth, Texas, United States
Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus
- Conditions
- Cataract
- Interventions
- Drug: Next Generation Ophthalmic Irrigating Solution (NGOIS)
- First Posted Date
- 2006-06-02
- Last Posted Date
- 2012-03-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 369
- Registration Number
- NCT00333268
- Locations
- 🇺🇸
United States, Fort Worth, Texas, United States
Uric Acid and Hypertension in African Americans
- Conditions
- Cardiovascular DiseasesHeart DiseasesHypertension
- Interventions
- First Posted Date
- 2005-10-19
- Last Posted Date
- 2013-07-26
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 150
- Registration Number
- NCT00241839
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Pre-ESRD Syndrome in High Risk African Americans
- Conditions
- Blood Pressure
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2010-01-14
- Target Recruit Count
- 144
- Registration Number
- NCT00224939
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
HalfLytely Bowel Prep System for Colonoscopy
- Conditions
- Colonoscopy
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2013-02-07
- Lead Sponsor
- Braintree Laboratories
- Target Recruit Count
- 200
- Registration Number
- NCT00164164
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.